Liulin Wu

Papers

Total Citations

H-Index

About

Dr. Liulin Wu is a pioneering researcher at the intersection of nanomedicine and precision therapeutics, with a primary focus on developing intelligent, feedback-regulated drug delivery systems for thrombolysis. Their most notable contribution is the design of an artificial biomarker-based platform that addresses the critical limitations of conventional body weight-based thrombolytic strategies—namely, low recanalization rates and high hemorrhagic risk. By elucidating the relationship between thrombus heterogeneity and thrombolysis resistance, Dr. Wu’s work introduces a personalized, feedback-regulated approach that dynamically adjusts treatment in response to real-time biomarkers, significantly reducing off-target bleeding. This landmark study, published in 2025, has already garnered 6 citations, signaling its rapid impact on the field. Dr. Wu’s research holds transformative potential for clinical stroke management, offering a safer, more effective alternative to current protocols. Their innovative integration of artificial biomarkers with precise drug release mechanisms marks a major step toward truly personalized thrombolytic therapy, positioning Dr. Wu as a rising leader in precision nanomedicine.